Sanofi
SNY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001121404
No open-market purchases or sales by Sanofi insiders were filed in the last 90 days; 718 institutions reported holding it in 13F filings for Q2 2026, worth $8.08B in total; Maverick Capital is the only superinvestor holding it.
Other share classesSNYNF
Superinvestors holding SNY, Q2 2026
1 superinvestor reports holding Sanofi on Form 13F, worth $2.20M in total. Weight is Sanofi's share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Maverick CapitalLee Ainslie | <0.1% | 51,572 | $2.20M | Added+109.8% |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of SNY each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+109.8%)
Q1 2026
1 superinvestor holding at quarter end
Q1 2025
0 superinvestors holding at quarter end
- Sold out
- Soros Fund Management
Q4 2024
1 superinvestor holding at quarter end
- Reduced
- Soros Fund Management (−50.0%)
Q3 2024
1 superinvestor holding at quarter end
- Added
- Soros Fund Management (+166.7%)
- Sold out
- Viking Global Investors
Q2 2024
2 superinvestors holding at quarter end
- New
- Viking Global Investors
- Reduced
- Soros Fund Management (−53.8%)
Q4 2023
1 superinvestor holding at quarter end
- Added
- Soros Fund Management (+51.2%)
Q3 2023
1 superinvestor holding at quarter end
Q2 2023
0 superinvestors holding at quarter end
Q1 2023
2 superinvestors holding at quarter end
- New
- HHLR Advisors (Hillhouse)
- Added
- Maverick Capital (+66.8%)
Q4 2022
1 superinvestor holding at quarter end